期刊文献+

尿激酶溶栓联合不同抗凝剂治疗ST段抬高型急性心肌梗死对心脏超声指数的影响 被引量:8

下载PDF
导出
摘要 目的比较ST段抬高型急性心肌梗死(STEMI)行溶栓联合重组水蛭素或低分子肝素两种不同抗凝治疗的疗效。方法 30例STEMI患者分为治疗组和对照组。治疗组(=15)溶栓治疗后即给重组水蛭素10 mg,每12小时脐周皮下注射,连续10d;对照组(=15)在溶治疗后即给低分子肝素钙5000U,每12小时脐周皮下注射,连续10 d。结果溶栓后14 d,两组血管再通率无显著差别;但治疗组射血分数、心输出量及心脏指数均显著高于对照组(均<0.05)。结论 STEMI行溶栓治疗后联合重组水蛭素抗凝对于改善心脏超声指数显著优于低分子肝素钙。
出处 《现代实用医学》 2011年第7期806-808,共3页 Modern Practical Medicine
  • 相关文献

参考文献7

  • 1胡大一.急性ST段抬高心肌梗死溶栓治疗的中国专家共识(2009年版)(上)[J].中国临床医生杂志,2010,38(10):70-73. 被引量:25
  • 2Llevadot J, Giugliano RP, Antman EM. Bolus fibrinolytic therapy in acute myoc- ardial infarction [J]. JAMA, 2001, 286(4): 442-449.
  • 3Ross AM, Gao R, Coyne KS, et al. A ran- domized trial confirming the efficacy of reduced dose recombinant tissue plasmi- nogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial [J]. Am Heart J, 2001, 142(2): 244-247.
  • 4Simpson E, Pilote L. Quality of life after acute myocardial infarction: a systematic review [J]. Can J Cardiol, 2003, 19(5):507-511.
  • 5Eagle KA, Nallamothu BK, Mehta RH, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarc- tion from 1999 to 2006: we are getting better but we have got a long way to go [J].Eur Heart J, 2008, 29(5):609-617.
  • 6Neuhaus KL, von Essen R, Tebbe U, et al. Improved thrombolysis in acute myocar- dial infarction with front-loaded adminis- tration of alteplase: results of the rt-PA- APSAC patency study (TAPS) [J]. J Am Coil Cardiol, 1992, 19(5): 885-891.
  • 7莫炜,宋后燕.重组水蛭素临床应用的研究进展[J].国外医学(药学分册),2004,31(2):82-86. 被引量:7

二级参考文献31

  • 1杨艳敏,朱俊,谭慧琼,梁岩,章晏,李建东,刘力生,CREATE中国课题组.中国ST段抬高的急性心肌梗死临床特征及治疗现状[J].中华医学杂志,2005,85(31):2176-2182. 被引量:86
  • 2DeWood MA,Spores J,Notske R,et al.Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction[J].N Engl J Med,1980,303:897-902.
  • 3Eagle KA,Nallamothu BK,Mehta RH,et al.Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006:we are getting better but we have got a long way to go[J].Eur Heart J,2008,29:609-617.
  • 4Chen ZM,Jiang LX,Chen YP,et al.Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction:randomised placebo-controlled trial[J].Lancet,2005,366:1607-1621.
  • 5Llevadot J,Giugliano RP,Antman EM.Bolus fibrinolytic therapy in acute myocardial infarction[J].JAMA,2001,286:422-429.
  • 6Ross AM,Gao R,Coyne KS,et al.A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase:the TUCC trial[J].Am Heart J,2001,142:244-247.
  • 7Hennekens CH, O′ Donnell CJ, Ridker PM. Current and future perspectives on antithrombotic therapy of acute myocardial infarction[J]. Eur Heart J, 1995, 16(Suppl D):2-9.
  • 8Simpson E, Pilote L. Quality of life after acute myocardial infarction: a systematic review[J]. Can J Cardiol, 2003,19(5):507-511.
  • 9Neuhaus KL, von Essen R, Tebbe U, et al. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study(TAPS)[J]. JAm Coll Cardiol, 1992, 19(5):885 - 891.
  • 10van de Loo A, Bode C. Hirudin in acute coronary syndromes[J]. Semin Thromb Hemost, 2002, 28(5):459 -466.

共引文献30

同被引文献54

引证文献8

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部